Handa Pharmaceuticals, Inc. (TPEX: 6620)

Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	11,047	25,891	16,074	8,451	2,820	3,477
Market Cap Growth	-35.17%	61.07%	90.20%	199.72%	-18.91%	3.61%
Enterprise Value	8,556	23,747	15,869	8,249	2,326	2,919
Last Close Price	78.30	182.21	120.73	67.04	23.53	29.02
PE Ratio	24.15	33.74	-377.28	-31.87	-9.64	-17.91
PS Ratio	11.23	23.40	81.32	289.08	97.71	41.36
PB Ratio	3.81	9.39	22.29	18.25	5.23	4.23
P/FCF Ratio	14.83	38.79	-75.75	-45.73	-8.93	-14.75
P/OCF Ratio	19.84	38.74	-75.98	-47.15	-9.14	-14.80
EV/Sales Ratio	8.79	21.46	80.28	282.15	80.61	34.72
EV/EBITDA Ratio	15.82	34.00	-195.20	-33.66	-7.53	-14.95
EV/EBIT Ratio	16.12	34.25	-180.08	-32.49	-7.33	-14.24
EV/FCF Ratio	11.49	35.58	-74.78	-44.63	-7.36	-12.38
Debt / Equity Ratio	0.01	0.00	0.04	0.03	0.02	0.02
Debt / EBITDA Ratio	0.07	0.02	-	-	-	-
Debt / FCF Ratio	0.05	0.02	-0.14	-0.06	-0.04	-0.09
Asset Turnover	0.43	0.58	0.31	0.05	0.04	0.10
Quick Ratio	17.71	12.93	11.63	10.05	9.05	15.60
Current Ratio	17.75	12.96	13.07	10.57	10.79	16.71
Return on Equity (ROE)	21.92%	41.81%	-6.76%	-49.43%	-41.47%	-23.73%
Return on Assets (ROA)	14.66%	22.64%	-8.54%	-29.36%	-27.20%	-15.98%
Return on Capital (ROIC)	15.71%	24.62%	-8.99%	-30.89%	-28.46%	-16.84%
Earnings Yield	4.14%	2.81%	-0.25%	-2.93%	-10.00%	-5.11%
FCF Yield	6.74%	2.58%	-1.32%	-2.19%	-11.20%	-6.78%
Dividend Yield	1.22%	0.55%	-	-	-	-
Buyback Yield / Dilution	-7.81%	-7.29%	-6.65%	-1.87%	-5.35%	-4.89%
Total Shareholder Return	-6.59%	-6.74%	-6.65%	-1.87%	-5.35%	-4.89%

Source: S&P Capital IQ. Standard template. Financial Sources.